The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has granted ...

The Subject Expert Committee functioning under the Central Drugs Standard Control Organisation (CDSCO) has opined Mankind Pharma should first conduct a Phase I clinical trial in ...

Careful consideration of individual patient factors and thorough consultations are key for pharmacists to maximize their impact on cancer care access and adherence, according to Ryan Haumschild, ...

Advances in CAR T-cell therapy and bispecific antibodies have expanded treatment options, though access challenges remain. Medicaid expansion has enhanced cancer care in Louisiana, boosting access to ...

A promising natural compound may offer new hope for treating one of the most aggressive forms of leukaemia. A natural ...

Start your day with a light meal, unless your doctor has said otherwise. Be sure to dress comfortably and wear something that ...

Around the world, doctors, nurses and pharmacists are turning to evidence-based integrative approaches such as acupuncture, yoga, exercise, massage and nutrition counseling to help people with cancer ...

Onco360(R) , the nation's leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Bayer Pharmaceuticals for HYRNUO(R) (sevabertinib). The Food and Drug ...

HYRNUO is a reversible kinase inhibitor of human epidermal growth factor receptor 2 (HER2). In vitro, HYRNUO inhibited the phosphorylation of HER2, downstream signaling in cancer cells with HER2 ...

Anktiva is combined with BCG, or Bacillus Calmette-Guérin, an immunotherapy drug delivered to the bladder through a catheter.

With a phase 3 win for a combination of its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) ...

The Global Generic Drugs Market, valued at USD 487.21 Billion in 2024, is poised to reach USD 898 Billion by 2035, advancing ...